CoreLink Hits Milestone of 5,000 Implants with 3D-Printed Technology
CoreLink has implanted over 5,000 3D-printed spinal devices that employ proprietary Mimetic Metal® additively-manufactured technology. ...
Jan 16, 2020,
CoreLink Hits Milestone of 5,000 Implants with 3D-Printed Technology
Rejoint YourKnee Receives CE Mark Approval
REJOINT received CE Mark approval for the YourKnee™ patient-specific 3D-printed total knee replacement....
Jan 16, 2020,
Embody Gains Additional Funding for ACL Repair
Embody is receiving a $2.5 million Phase II research award. Funds will support development and clinical assessment of collagen-based MICROBRACE™ ACL technology for...
Jan 14, 2020,
RTI Surgical to Become Pure Play Spine Company with Sale of OEM Business
RTI Surgical announced a definitive agreement to sell their OEM business to Montagu Private Equity LLP for a total of...
Jan 14, 2020,
Medicrea Announces Partnership Discussions and Proposed Capital Increase
Medicrea announced a preliminary discussion for acquisition by or partnership with U.S. spine players as well as a proposed capital...
Jan 14, 2020,
Biologics4Life Secures License to Bone Tissue Regeneration Technology
Biologics4Life completed an exclusive licensing agreement to secure rights to initial technologies for bone tissue regeneration....
Jan 10, 2020,
EnMovi Formed to Develop Wearable/Data Analytics Tool for Orthopedic Procedures
OrthoSensor and McLaren Applied formed EnMovi to expand development of MOTIONSENSE™ wearable sensor technology and ORTHOLOGIQ® data analytics for use...
Jan 10, 2020,
Cutting Edge Spine Gains FDA Clearance of EVOLha-DLIF
Cutting Edge Spine received FDA 510(k) clearance of the EVOL®ha-DLIF direct lateral interbody fusion system....
Jan 09, 2020,
Silver Bullet Therapeutics Gains CE Mark for OrthoFuzIon Bone Screw
Silver Bullet Therapeutics received CE Mark approval for the OrthoFuzIon™ Bone Screw for reduction and internal fixation procedures anywhere in the...
Jan 09, 2020,
Royal Biologics Launches MAGNUS DMSO-Free Viable Cellular Bone Allograft
Royal Biologics launched MAGNUS, a viable cellular bone allograft that uses a DMSO-free cryoprotectant....
Jan 09, 2020,
Loading new posts...
No more posts
